Invasive aspergillosis in critically ill patients: Analysis of risk factors for acquisition and mortality

Acta Clinica Belgica

Volumn 59, Issue 5, 2004, Pages 251-257

  Vandewoude, K ^a   Blot, S ^a   Benoit, D ^a   Depuydt, P ^a   Vogelaers, D ^a   Colardyn, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Intensive care; Invasive aspergillosis; Outcome

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BURN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; GRAFT REJECTION; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTENSIVE CARE UNIT; LIVER FAILURE; MAJOR CLINICAL STUDY; MALNUTRITION; MICROBIOLOGY; MORTALITY; NEUTROPENIA; PNEUMONIA; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; TISSUE CULTURE;

EID: 11144290975     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2004.037     Document Type: Article

References (24)

1. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114: 629-34.
2. Karam GH, Griffin FM, Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis. 1986; 8: 357-63.
3. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis. 1998; 26: 1473-5.
4. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, Fagan E, Williams R. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991; 12: 1-9.
5. Engelich G, Wright DG, Hartshorn KL. Acquired disorders of phagocyte function complicating medical and surgical illnesses. Clin Infect Dis. 2001; 33: 2040-8.
6. Blot S, Vandewoude K. Early detection of systemic infections. Acta Clin Belg. 2004; 59: 20-3.
7. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998; 26: 781-803; quiz 804-785.
8. Knaus WA, Draper EA, Wagner DP, Zimmerman J. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13: 818-29.
9. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002; 34:7-14.
10. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002; 113:480-5.
11. Noble JS, MacKirdy FN, Donaldson SI, Howie JC. Renal and respiratory failure in Scottish ICUs. Anaesthesia 2001; 56:124-9.
12. Groeneveld AB, Tran DD, van der Meulen J, Nauta JJ, Thijs LG. Acute renal failure in the medical intensive care unit: pre-disposing, complicating factors and outcome. Nephron 1991; 59: 602-10.
13. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and Attributable Mortality in Critically Ill Patients With Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus. Arch Intern Med. 2002; 162: 2229-35.
14. Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis. 2002; 34:1600-6.
15. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect. 1996; 33: 23-32.
16. Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol. 1999; 37: 1732-8.
17. Chandrasekar PH, Alangaden G, Manavathu E. Aspergillus: an increasing problem in tertiary care hospitals? Clin Infect Dis. 2000 30: 984-5.
18. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998; 27: 1138-47.
19. Dimopoulos G, Piagnerelli M, Berré J, Eddafli B, Salmon I, Vincent J-L. Disseminated Aspergillosis in Intensive Care Patients: an Autopsy Study. J Chemother. 2003; 15: 71-75.
20. Temmerman W, Benoit D, Vandewoude K, Decruyenaere J, Colardyn F. Invasive aspergillosis in the ICU: incidence and characteristics. Intensive Care Med. 2000; 26:S 376, abstract 638.
21. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Micmbiol Infect Dis. 2002; 21:161-72.
22. Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001; 33: 1824-33.
23. Janssen JJ, Strack van Schijndel RJ, van der Poest Clement EH, Ossenkoppele GJ, Thijs LG, Huijgens PC. Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med. 1996; 22: 1315-22.
24. Vandewoude K, Blot S, Benoit D, Colardyn F, Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect. 2004; 56: 269-76.